Page last updated: 2024-09-03

tazobactam and Kidney Failure, Chronic

tazobactam has been researched along with Kidney Failure, Chronic in 9 studies

Research

Studies (9)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	3 (33.33)	29.6817
2010's	5 (55.56)	24.3611
2020's	1 (11.11)	2.80

Authors

Authors	Studies
Choi, JY; Ko, KS; Lee, MY; Park, YK; Peck, KR; Rhee, JY; Shin, JY; Song, JH	1
Bruno, CJ; De Anda, C; Feng, HP; Fiedler-Kelly, J; Gao, W; Patel, YT; Rhee, EG; Zhang, Z	1
Alessa, MA; Alhokail, M; Alhossan, A; Alkholief, MA; Almangour, TA; Tabb, DE	1
Cheng, V; Dyer, J; Ingram, P; McWhinney, BC; Raby, E; Rawlins, M; Regli, A; Roberts, JA; Ungerer, JPJ	1
Chandorkar, G; Hershberger, E; Krishna, G; Miller, B; Wooley, M	1
Chao, CM; Chiu, YH; Hou, CC; Lai, CC; Liu, WL	1
Bassilios, N; Restoux, A; Rondeau, E; Sraer, JD; Vincent, F	1
Kwan, TH; Siu, YP; Tong, MK; Yung, CY	1
Arzuaga, A; Canut, A; Corral, E; Fonseca, F; Gascón, AR; Isla, A; Maynar, J; Pedraz, JL; Rello, J; Sánchez-Izquierdo, JA	1

Trials

1 trial(s) available for tazobactam and Kidney Failure, Chronic

Article	Year
Probability of Target Attainment Analyses to Inform Ceftolozane/Tazobactam Dosing Regimens for Patients With Hospital-Acquired or Ventilator-Associated Bacterial Pneumonia and End-Stage Renal Disease Receiving Intermittent Hemodialysis. Journal of clinical pharmacology, 2023, Volume: 63, Issue:2 Topics: Anti-Bacterial Agents; Cephalosporins; Hospitals; Humans; Kidney Failure, Chronic; Microbial Sensitivity Tests; Pneumonia, Bacterial; Pneumonia, Ventilator-Associated; Probability; Renal Dialysis; Tazobactam; Ventilators, Mechanical	2023

Article

Year

Probability of Target Attainment Analyses to Inform Ceftolozane/Tazobactam Dosing Regimens for Patients With Hospital-Acquired or Ventilator-Associated Bacterial Pneumonia and End-Stage Renal Disease Receiving Intermittent Hemodialysis.

Journal of clinical pharmacology, 2023, Volume: 63, Issue:2

Topics: Anti-Bacterial Agents; Cephalosporins; Hospitals; Humans; Kidney Failure, Chronic; Microbial Sensitivity Tests; Pneumonia, Bacterial; Pneumonia, Ventilator-Associated; Probability; Renal Dialysis; Tazobactam; Ventilators, Mechanical

2023

Other Studies

8 other study(ies) available for tazobactam and Kidney Failure, Chronic

Article	Year
KPC-producing extreme drug-resistant Klebsiella pneumoniae isolate from a patient with diabetes mellitus and chronic renal failure on hemodialysis in South Korea. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:5 Topics: Aged; beta-Lactamases; Diabetic Nephropathies; Humans; Kidney Failure, Chronic; Klebsiella Infections; Klebsiella pneumoniae; Male; Renal Dialysis; Republic of Korea	2010
Ceftolozane-tazobactam for the treatment of multidrug-resistant American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2018, May-01, Volume: 75, Issue:9 Topics: Aged; Anti-Bacterial Agents; Cephalosporins; Drug Resistance, Multiple, Bacterial; Humans; Kidney Failure, Chronic; Male; Microbial Sensitivity Tests; Pneumonia, Bacterial; Pseudomonas aeruginosa; Pseudomonas Infections; Renal Dialysis; Tazobactam; Treatment Outcome	2018
Pharmacokinetics of Ceftolozane-Tazobactam during Prolonged Intermittent Renal Replacement Therapy. Chemotherapy, 2018, Volume: 63, Issue:4 Topics: Anti-Bacterial Agents; Cephalosporins; Female; Half-Life; Humans; Kidney Failure, Chronic; Middle Aged; Osteomyelitis; Pseudomonas aeruginosa; Renal Replacement Therapy; Tazobactam	2018
Impact of renal function on the pharmacokinetics and safety of ceftolozane-tazobactam. Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:4 Topics: Adolescent; Adult; Aged; Cephalosporins; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Penicillanic Acid; Prospective Studies; Tazobactam; Young Adult	2014
Biliary tract infection caused by Vibrio fluvialis in an immunocompromised patient. Infection, 2011, Volume: 39, Issue:5 Topics: Abdominal Pain; Aged, 80 and over; Anti-Bacterial Agents; Bile Ducts, Intrahepatic; Choledocholithiasis; Diabetes Mellitus; Diagnosis, Differential; Female; Gallstones; Humans; Immunocompromised Host; Kidney Failure, Chronic; Liver Cirrhosis; Penicillanic Acid; Piperacillin; Risk Factors; Taiwan; Tazobactam; Treatment Outcome; Vibrio; Vibrio Infections; Vomiting	2011
Piperacillin/Tazobactam inducing seizures in a hemodialysed patient. Clinical nephrology, 2002, Volume: 58, Issue:4 Topics: Enzyme Inhibitors; Female; Humans; Kidney Failure, Chronic; Middle Aged; Penicillanic Acid; Penicillins; Piperacillin; Renal Dialysis; Seizures; Tazobactam; Treatment Failure	2002
Piperacillin/tazobactam-induced acute delirium in a peritoneal dialysis patient. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2004, Volume: 19, Issue:5 Topics: Anti-Bacterial Agents; Bacterial Infections; Confusion; Delirium; Drug Therapy, Combination; Gram-Positive Bacterial Infections; Hallucinations; Humans; Kidney Failure, Chronic; Male; Middle Aged; Penicillanic Acid; Peritoneal Dialysis, Continuous Ambulatory; Piperacillin; Tazobactam	2004
Influence of renal function on the pharmacokinetics of piperacillin/tazobactam in intensive care unit patients during continuous venovenous hemofiltration. Journal of clinical pharmacology, 2005, Volume: 45, Issue:2 Topics: Aged; Area Under Curve; Chromatography, High Pressure Liquid; Critical Care; Drug Therapy, Combination; Female; Half-Life; Hemofiltration; Humans; Inpatients; Intensive Care Units; Kidney; Kidney Failure, Chronic; Male; Microbial Sensitivity Tests; Middle Aged; Penicillanic Acid; Piperacillin; Tazobactam; Time Factors	2005